---
title: "CDC director files to sell her entire Butterfly (BFLY) stake one day after the 22% pop"
description: "Erica Schwartz's Form 144 covers all 401,699 shares she reported owning, marked at $10, the morning after Needham's initiation sent the stock up 22%. The CEO's sales were automatic or pre-scheduled, and he still holds 7.35 million shares."
publisher: "The Inference"
section: "Health"
published: 2026-09-24T18:17:19.065Z
modified: 2026-09-24T18:17:19.065Z
canonical: https://theinference.org/article/cdc-director-files-to-sell-her-entire-butterfly-stake-one-day-after-the-22-pop
language: en
keywords: "Insider Selling, Butterfly Network, CDC, SEC Filings, Medtech, Needham"
---

# CDC director files to sell her entire Butterfly (BFLY) stake one day after the 22% pop

> Erica Schwartz's Form 144 covers all 401,699 shares she reported owning, marked at $10, the morning after Needham's initiation sent the stock up 22%. The CEO's sales were automatic or pre-scheduled, and he still holds 7.35 million shares.

## The director who left for the CDC is selling everything on record

[Erica Schwartz](https://theinference.org/markets/people/erica-schwartz) stepped off [Butterfly Network](https://theinference.org/markets/companies/butterfly-network)'s board on 5 August 2026, the day [the Senate confirmed her to run the CDC](https://www.yahoo.com/news/politics/articles/erica-schwartz-confirmed-next-cdc-111200184.html) [4][5]. On 22 September, the day a Buy initiation sent the stock up 21.99% to $9.93 [3][10], she sold 78,679 Class A shares for $786,790 [1]. The next morning [her Form 144 reached EDGAR](https://www.stocktitan.net/sec-filings/BFLY/144-butterfly-network-inc-sec-filing-d5be63104495.html): 323,020 more shares, aggregate market value $3,230,200 [1].

Her most recent ownership filing, from 22 June, reported 401,699 shares [9]. The completed sale plus the pending block equals that position exactly. Rule 144 asks no reason, and none is given [1].

## The bull case is 2030 money with nothing shipped

Needham's David Saxon opened at Buy with a $10 target, a sum-of-the-parts at roughly 16 times the firm's 2027 sales estimate [3]. The model carries an estimated $300 million of [Midjourney](https://theinference.org/markets/companies/midjourney) licensing revenue at 2030 and about $25 million from Mendaera, and concedes no Embedded partnership has launched a commercial product; roughly two-thirds of sales are still the legacy probe business [3]. Sixteen times sales across 244.9 million shares implies about $150 million of 2027 revenue, a third more than the trailing four quarters delivered [1][11].

## Affiliates put 685,000 shares on the tape

President, CEO and chairman [Joseph DeVivo](https://theinference.org/markets/people/joseph-devivo) disclosed $2.07 million of July and August sales, then filed a fresh 2,811-share notice the afternoon of the pop [2]. Counting Schwartz's 401,699 shares, disclosed affiliate supply since July runs to about 685,000 shares, 0.28 percent of the 244,858,246 outstanding [1][2]. Small against the float. The signal is who sold, and when.

*Chart: **Butterfly insider blocks grew into the pop, and the biggest is still pending** Column chart of four Butterfly Network insider sale blocks by gross proceeds in millions of dollars, rising from 1.39 and 0.68 in July and August to 0.79 and a pending 3.23 in September.*

*Gross proceeds per disclosed Rule 144 block, July to September 2026, in millions of US dollars. The 23 September bar is Schwartz's intended sale at its stated aggregate market value; the other three are completed sales. From SEC Form 144 notices filed 22 and 23 September 2026. [1][2]*

## The biggest block is the one still pending

Schwartz's 22 September sale printed near $9.99 a share, within half a percent of the $10.05 52-week high [1][10]. The pending block is marked at exactly $10. Her notice lists five vesting tranches running back to June 2024 and no Rule 10b5-1 plan date; DeVivo's carries one, adopted 12 December 2025 [1][2]. The bull case is priced in 2030 dollars; the insider paper cleared at $10.

## The counter-read: the CEO is staying

DeVivo's July sale of 211,798 shares at an average $6.56 was a sell-to-cover for RSU taxes, automatic and not at his discretion, [his Form 4 states](https://www.sec.gov/Archives/edgar/data/1258790/000206483226000260/form4.xml) [7]. The August block ran under the December plan, adopted long before the run [8]. He still held 7,353,700 shares after gifting 250,000 to trusts for his children, about $69 million at Wednesday's $9.42 close [6][3]. Buyers met the tape too: 33 hedge funds held $425 million of the stock at the end of June, up from $171 million a quarter earlier [10].

## What settles it

Earnings are due around 30 October, guided to $26 to $30 million of revenue and adjusted EBITDA between negative $9 million and negative $6 million [10]. Butterfly has lost money in each of the last eight quarters while cash fell to $124.7 million at midyear [11]. The tells are the first commercial Embedded shipment, and the Form 4 that follows her last 323,020 shares out the door.

*Chart: **Revenue is growing, but Butterfly has lost money for ten straight quarters** Line chart of Butterfly Network quarterly revenue rising from $17.7 million in Q1 2024 to $32.6 million in Q2 2026, with net income negative in all ten quarters, between negative $12.7 million and negative $34 million.*

*Quarterly revenue and net income, Q1 2024 to Q2 2026, in millions of US dollars. Butterfly has posted a net loss in each of the last ten quarters, including the eight cited in the story. From Sharadar quarterly fundamentals, from Butterfly Network's SEC filings. [11]*

## Takeaway

Erica Schwartz left Butterfly Network's board the day the Senate confirmed her as CDC director, and six weeks later she filed to sell every share she has ever reported owning: 78,679 sold into the 22 percent pop a Buy initiation created, and 323,020 more marked at exactly the $10 target the morning after. The sale is small against the float and the CEO's own selling was automatic or pre-scheduled, but her notice carries no 10b5-1 plan date, and it landed while the bull case rests on 2030 licensing revenue from partnerships that have yet to ship a product.

## Sources

1. [StockTitan, Form 144 notice, Erica Schwartz, Butterfly Network, 23 September 2026](https://www.stocktitan.net/sec-filings/BFLY/144-butterfly-network-inc-sec-filing-d5be63104495.html)
2. [StockTitan, Form 144 notice, Joseph DeVivo, Butterfly Network, 22 September 2026](https://www.stocktitan.net/sec-filings/BFLY/144-butterfly-network-inc-sec-filing-d51f822f24af.html)
3. [Benzinga, Butterfly Stock Retreats: What's Going On Today?, 23 September 2026](https://www.benzinga.com/trading-ideas/movers/26/09/61949139/butterfly-stock-retreats-whats-going-on-today)
4. [Business Wire via Morningstar, Butterfly Network Congratulates Dr. Erica Schwartz on Confirmation as CDC Director, 11 August 2026](https://www.morningstar.com/news/business-wire/20260811359591/butterfly-network-congratulates-dr-erica-schwartz-on-confirmation-as-cdc-director)
5. [BioPharma Dive via Yahoo News, Erica Schwartz confirmed as next CDC director, 6 August 2026](https://www.yahoo.com/news/politics/articles/erica-schwartz-confirmed-next-cdc-111200184.html)
6. [SEC EDGAR, Butterfly Network Form 4, Joseph DeVivo, gift of 250,000 shares, filed 25 August 2026](https://www.sec.gov/Archives/edgar/data/1258790/000206483226000280/form4.xml)
7. [SEC EDGAR, Butterfly Network Form 4, Joseph DeVivo, sale of 211,798 shares, filed 21 July 2026](https://www.sec.gov/Archives/edgar/data/1258790/000206483226000260/form4.xml)
8. [SEC EDGAR, Butterfly Network Form 4, Joseph DeVivo, sale of 68,346 shares, filed 12 August 2026](https://www.sec.gov/Archives/edgar/data/1258790/000206483226000268/form4.xml)
9. [SEC EDGAR, Butterfly Network Form 4, Erica Schwartz, director RSU grant showing 401,699 shares held, filed 22 June 2026](https://www.sec.gov/Archives/edgar/data/1872122/000206483226000240/form4.xml)
10. [NAI 500, BFLY Pops on Buy Call, Hedge Funds Pile In, 24 September 2026](https://nai500.com/blog/2026/09/bfly-pops-on-buy-call-hedge-funds-pile-in/)
11. [Sharadar quarterly fundamentals for Butterfly Network, from SEC filings, retrieved 24 September 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001804176)


---

CDC director files to sell her entire Butterfly (BFLY) stake one day after the 22% pop — The Inference. Canonical: https://theinference.org/article/cdc-director-files-to-sell-her-entire-butterfly-stake-one-day-after-the-22-pop
